A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy-Reference-Cited by-同舟云学术

A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy

Published:2009-10 Issue:10 Volume:39 Page:1569-1574
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:

Author:

Schiappoli M.,Ridolo E.,Senna G.,Alesina R.,Antonicelli L.,Asero R.,Costantino M. T.,Longo R.,Musarra A.,Nettis E.,Crivellaro M.,Savi E.,Massolo A.,Passalacqua G.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2222.2009.03286.x/fullpdf

Reference27 articles.

1. 1 Bousquet J , Lockey RF , Malling HJ , eds. WHO position paper allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998; (Suppl. 44):1-42.

2. 2 Bousquet J , Van de Cauwenberge P , eds. Allergic Rhinitis and its Impact on Asthma (ARIA) WHO Position Paper. J Allergy Clin Immunol 2001; 108 (Suppl. 5):S147-334.

3. 3 Bonifazi F , Jutel M et al. EAACI Interest Group on Insect Venom Hypersensitivity. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005; 60:1459-70.

4. 4 Lockey RF , Benedicts LM , Turkeltaub PC , Platt-Mills TA. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987; 76:660-77.

5. 5 Reid MJ , Lockey RF , Turkeltaub PC , Platt-Mills TA. Survey of fatalities from skin testing and immunotherapy. J Allergy Clin Immunol 1993; 92:6-15.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allergen immunotherapy adverse events in adults with respiratory allergies‐data from ADER: An EAACI task force report;Allergy;2024-08-22

2. Is It Possible to Predict Systemic Adverse Effects in Subcutaneous Allergen Immunotherapy? Single-Center Experience;International Archives of Allergy and Immunology;2024-06-26

3. Characteristics of adverse reactions due to subcutaneous allergen immunotherapy applied between 2011-2021: Single center experience;Tuberk Toraks;2023-12-26

4. Modification of allergen subcutaneous immunotherapy safety precautions and systemic allergic reaction rate reduction;Immunotherapy;2023-11

5. Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce;Clinical and Translational Allergy;2023-06